FDA Drug Application (022505) for EGRIFTA by THERATECHNOLOGIES

Back to FDA Applications sponsored by THERATECHNOLOGIES

Application Number022505
Product Number001
FormPOWDER;SUBCUTANEOUS
DosageEQ 1MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEGRIFTA
Active IngredientTESAMORELIN ACETATE



Back to FDA Applications sponsored by THERATECHNOLOGIES

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.